Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

NCT00849615 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Adenocarcinoma of the Esophagogastric Junction

Interventions

DRUG: Docetaxel
DRUG: 5-Fluorouracil
DRUG: Oxaliplatin
DRUG: folinic acid

Sponsor

Krankenhaus Nordwest